Featured November 3, 2024 Autonomous Therapeutics and Mink Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors November 3, 2024 November 3, 2024 November 3, 2024 Autonomous CEO, Dr. Ariel Weinberger, serves on keynote panel at World Vaccine & Immunotherapy Congress November 3, 2024 November 3, 2024 November 3, 2024 Autonomous CEO, Dr. Ariel Weinberger, gives plenary presentation at NIH Synthetic Biology Consortium Meeting November 3, 2024 November 3, 2024 November 3, 2024 Autonomous Therapeutics wins $1 million Blue Knight™ QuickFire Challenge November 3, 2024 November 3, 2024 September 19, 2023 Keynote Panel @ RNA Leaders USA Congress September 19, 2023 September 19, 2023 April 15, 2023 Op-Ed in BioCentury: The urgent need for variant-proof therapeutics April 15, 2023 April 15, 2023 April 15, 2023 Autonomous Therapeutics, CEO, Dr. Ariel Weinberger, interviewed by Vaccine Nation about next-generation mRNA therapeutics and antivirals April 15, 2023 April 15, 2023 November 21, 2021 Autonomous CEO, Dr. Ariel Weinberger, presents on novel mRNA therapeutic technologies at the World Antiviral Congress November 21, 2021 November 21, 2021 January 19, 2021 BioBuzz Interviews Autonomous Therapeutics CEO Ariel Weinberger January 19, 2021 January 19, 2021 October 19, 2020 Antiviral drug company working on Covid-19 relocates to Rockville October 19, 2020 October 19, 2020
